Revolutionize your pipetting – use the brand-new Biohit Picus
Biohit Picus is a brand-new electronic pipette that is designed with laboratory personnel in mind. As a result, it is small, lightweight and extremely easy to use more
BIOSTAT® B-DCU II – the power and flexibility to meet your process development needs
BIOSTAT® B-DCU II – the power and flexibility to meet your process development needs
BIOSTAT® B-DCU II – the power and flexibility to meet your process development needs
BIOSTAT® B-DCU II – the power and flexibility to meet your process development needs
The BIOSTAT® B-DCU II is designed for meeting demanding requirements in both research and process development.
Unrivaled for scale-down and scale-up modeling of various culture processes, the BIOSTAT® B-DCU II provides highest level of power and flexibility and can be configured with up to six supply towers, each providing independent control of the respective culture vessel
Revolutionize your pipetting – use the brand-new Biohit Picus
Biohit Picus is a brand-new electronic pipette that is designed with laboratory personnel in mind. As a result, it is small, lightweight and extremely easy to use more
Sartorius Off to a Good Start in 2012
Sartorius started off fiscal 2012 with substantial gains in order intake, sales revenue and earnings. Based on the company's excellent quarterly performance, management confirmed its full-year guidance: “In all divisions and regions, we are well on track. It is also encouraging that we have ... more
Sartorius Reviews Fiscal 2011 Results
Sartorius closed the year 2011 with double-digit sales growth and boosted its earnings by nearly a third. At the annual press conference for the company in Goettingen, Germany, Group CEO Dr. Joachim Kreuzburg indicated that 2011 was an especially forward-looking year beyond the company’s fi ... more
Sartorius grows at double-digit rates and boosts operating earnings by more than 30%
Sartorius grew dynamically yet again in 2011 and significantly expanded its profitability. Both Group divisions reported highs in sales revenue and earnings. The financial targets that the company had raised twice before year-end were fully achieved. Sartorius expects positive business deve ... more